导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 41.35% | 238/969 |
| 近一周 | -1.98% | 742/1048 |
| 近一月 | -0.94% | 396/1046 |
| 近一季 | -1.89% | 625/1033 |
| 近半年 | 31.73% | 292/1007 |
| 近一年 | 37.87% | 239/964 |
| 近两年 | 42.89% | 316/880 |
| 近三年 | 37.93% | 159/780 |
| 成立以来 | 219.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
10.69% 137/1014 |
1.77% 528/1038 |
41.01% 177/1050 |
- - |
| 2024 | 3.08% 496/1011 |
-14.10% 890/960 |
-0.56% 343/983 |
16.00% 178/991 |
4.03% 162/1011 |
| 2023 | -4.82% 199/952 |
29.12% 14/880 |
-7.01% 643/895 |
-14.75% 767/915 |
-7.02% 679/952 |
| 2022 | -20.02% 322/867 |
-24.11% 708/773 |
-6.19% 765/806 |
-3.52% 40/845 |
16.42% 31/867 |
| 2021 | 30.79% 68/740 |
-6.50% 401/580 |
32.90% 39/659 |
-4.49% 331/704 |
10.20% 80/740 |
| 2020 | 50.76% 236/554 |
5.13% 74/419 |
21.85% 253/466 |
4.31% 372/517 |
12.83% 259/554 |
| 2019 | 56.15% 101/410 |
38.90% 73/1146 |
-9.97% 1058/1228 |
15.24% 36/390 |
8.36% 223/410 |
| 2018 | -12.77% 18/349 |
- - |
-20.54% 906/990 |
2.59% 109/1000 |
-5.18% 55/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 中欧电子信息产业沪港深股票A VS. () |